Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

[Hemodynamic Definition of Pulmonary Hypertension: Commentary on the Proposed Change by the 6th World Symposium on Pulmonary Hypertension].

Rosenkranz S, Diller GP, Dumitrescu D, Ewert R, Ghofrani HA, Grünig E, Halank M, Held M, Kaemmerer H, Klose H, Kovacs G, Konstantinides S, Lang IM, Lange TJ, Leuchte H, Mayer E, Olschewski A, Olschewski H, Olsson KM, Opitz C, Schermuly RT, Seeger W, Wilkens H, Hoeper MM.

Dtsch Med Wochenschr. 2019 Sep;144(19):1367-1372. doi: 10.1055/a-0918-3772. Epub 2019 Jul 5. German.

2.

Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.

Barco S, Schmidtmann I, Ageno W, Bauersachs RM, Becattini C, Bernardi E, Beyer-Westendorf J, Bonacchini L, Brachmann J, Christ M, Czihal M, Duerschmied D, Empen K, Espinola-Klein C, Ficker JH, Fonseca C, Genth-Zotz S, Jiménez D, Harjola VP, Held M, Iogna Prat L, Lange TJ, Manolis A, Meyer A, Mustonen P, Rauch-Kroehnert U, Ruiz-Artacho P, Schellong S, Schwaiblmair M, Stahrenberg R, Westerweel PE, Wild PS, Konstantinides SV, Lankeit M; HoT-PE Investigators .

Eur Heart J. 2019 May 23. pii: ehz367. doi: 10.1093/eurheartj/ehz367. [Epub ahead of print]

PMID:
31120118
3.

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study).

Marra AM, Halank M, Benjamin N, Bossone E, Cittadini A, Eichstaedt CA, Egenlauf B, Harutyunova S, Fischer C, Gall H, Ghofrani HA, Hoeper MM, Lange TJ, Olsson KM, Klose H, Grünig E.

Respir Res. 2018 Dec 19;19(1):258. doi: 10.1186/s12931-018-0957-y.

4.

Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients.

Delcroix M, Staehler G, Gall H, Grünig E, Held M, Halank M, Klose H, Vonk-Noordegraaf A, Rosenkranz S, Pepke-Zaba J, Opitz CF, Gibbs JSR, Lange TJ, Tsangaris I, Huscher D, Pittrow D, Olsson KM, Hoeper MM.

Eur Respir J. 2018 Nov 8;52(5). pii: 1800248. doi: 10.1183/13993003.00248-2018. Print 2018 Nov.

PMID:
30337446
5.

Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertension.

Richter MJ, Harutyunova S, Bollmann T, Classen S, Gall H, Gerhardt Md F, Grimminger F, Grimminger J, Grünig E, Guth S, Halank M, Heine A, Hoeper MM, Klose H, Lange TJ, Meyer K, Neurohr C, Nickolaus K, Olsson KM, Opitz CF, Rosenkranz S, Seyfarth HJ, Warnke C, Wiedenroth C, Ghofrani HA, Ewert R.

J Heart Lung Transplant. 2018 Oct;37(10):1235-1244. doi: 10.1016/j.healun.2018.06.006. Epub 2018 Jun 21.

PMID:
30293617
6.

Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018.

Olsson KM, Halank M, Egenlauf B, Fistera D, Gall H, Kaehler C, Kortmann K, Kramm T, Lichtblau M, Marra AM, Nagel C, Sablotzki A, Seyfarth HJ, Schranz D, Ulrich S, Hoeper MM, Lange TJ.

Int J Cardiol. 2018 Dec 1;272S:46-52. doi: 10.1016/j.ijcard.2018.08.081. Epub 2018 Aug 26. Review.

PMID:
30190155
7.

Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018.

Olschewski H, Behr J, Bremer H, Claussen M, Douschan P, Halank M, Held M, Hoeper MM, Holt S, Klose H, Krüger S, Lange TJ, Reichenberger F, Skowasch D, Ulrich S, Wilkens H, Seeger W.

Int J Cardiol. 2018 Dec 1;272S:63-68. doi: 10.1016/j.ijcard.2018.08.043. Epub 2018 Aug 11. Review.

PMID:
30131231
8.

The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry.

Zelniker TA, Huscher D, Vonk-Noordegraaf A, Ewert R, Lange TJ, Klose H, Dumitrescu D, Halank M, Held M, Gall H, Pittrow D, Hoeper MM, Frankenstein L.

Clin Res Cardiol. 2018 Jun;107(6):460-470. doi: 10.1007/s00392-018-1207-5. Epub 2018 Jan 24.

PMID:
29368137
9.

Intravenous treprostinil infusion via a fully implantable pump for pulmonary arterial hypertension.

Ewert R, Richter MJ, Steringer-Mascherbauer R, Grünig E, Lange TJ, Opitz CF, Warnke C, Ghofrani HA.

Clin Res Cardiol. 2017 Oct;106(10):776-783. doi: 10.1007/s00392-017-1114-1. Epub 2017 Apr 20.

PMID:
28429083
10.

Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre Trial.

Grünig E, Benjamin N, Lange TJ, Krueger U, Klose H, Neurohr C, Wilkens H, Halank M, Seyfarth HJ, Held M, Traube A, Pernow M, Grover ER, Egenlauf B, Gerhardt F, Viethen T, Rosenkranz S.

Respiration. 2016;92(6):362-370. Epub 2016 Oct 27.

11.

[Pulmonary hypertension due to chronic lung disease: Recommendations of the Cologne Consensus Conference 2016].

Olschewski H, Behr J, Bremer H, Claussen M, Douschan P, Halank M, Held M, Hoeper MM, Holt S, Klose H, Krüger S, Lange TJ, Reichenberger F, Skowasch D, Ulrich S, Wilkens H, Seeger W.

Dtsch Med Wochenschr. 2016 Oct;141(S 01):S57-S61. Epub 2016 Oct 19. German.

PMID:
27760451
12.

[Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension].

Olsson KM, Halank M, Egenlauf B, Fistera D, Gall H, Kaehler C, Kortmann K, Kramm T, Lichtblau M, Marra A, Nagel C, Sablotzki A, Seyfarth HJ, Schranz D, Ulrich S, Hoeper MM, Lange TJ.

Dtsch Med Wochenschr. 2016 Oct;141(S 01):S42-S47. Epub 2016 Oct 19. Review. German.

PMID:
27760449
13.

Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.

Hoeper MM, Behr J, Held M, Grunig E, Vizza CD, Vonk-Noordegraaf A, Lange TJ, Claussen M, Grohé C, Klose H, Olsson KM, Zelniker T, Neurohr C, Distler O, Wirtz H, Opitz C, Huscher D, Pittrow D, Gibbs JS.

PLoS One. 2015 Dec 2;10(12):e0141911. doi: 10.1371/journal.pone.0141911. eCollection 2015.

14.

Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Marra AM, Egenlauf B, Ehlken N, Fischer C, Eichstaedt C, Nagel C, Bossone E, Cittadini A, Halank M, Gall H, Olsson KM, Lange TJ, Grünig E.

Int J Cardiol. 2015 Sep 15;195:19-26. doi: 10.1016/j.ijcard.2015.05.105. Epub 2015 May 19.

15.

[Dyspnoea in Patients with Pulmonary Hypertension (PH) - a Survey in Spezialized German PH Centres].

Ewert R, Wilkens H, Skowasch D, Reppel M, Bollmann T, Halank M, Held M, Klose H, Gall H, Lange TJ, Opitz CF, Seyfarth HJ, Winkler J.

Pneumologie. 2015 Jun;69(6):361-5. doi: 10.1055/s-0034-1391893. Epub 2015 Apr 21. German.

16.

[Imatinib for pulmonary arterial hypertension].

Hoeper MM, Opitz C, Olschewski H, Ulrich S, Speich R, Behr J, Halank M, Wilkens H, Klose H, Lange TJ, Grünig E, Seeger W, Ewert R, Borst MM, Welte T, Rosenkranz S, Ghofrani HA.

Dtsch Med Wochenschr. 2014 Dec;139 Suppl 4:S151-4. doi: 10.1055/s-0034-1387457. Epub 2014 Dec 9. Review. German. No abstract available.

PMID:
25489685
17.

[Targeted therapy of pulmonary arterial hypertension (PAH)].

Klose H, Opitz C, Bremer H, Ewert R, Bonderman D, Rosenkranz S, Seeger W, Schmeißer A, Harbaum L, Buerke M, Ghofrani HA, Borst MM, Leuchte HH, Lange TJ, Behr J, Ulrich S, Lang I, Olschewski H, Gall H, Kabitz HJ, Kleber FX, Held M, Hoeper MM, Grünig E.

Dtsch Med Wochenschr. 2014 Dec;139 Suppl 4:S142-50. doi: 10.1055/s-0034-1387489. Epub 2014 Dec 9. Review. German. No abstract available.

PMID:
25489684
18.

Response to letters regarding article, "Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)".

Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange TJ, Behr J, Klose H, Claussen M, Ewert R, Opitz CF, Vizza CD, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper MM.

Circulation. 2014 Sep 16;130(12):e110-2. doi: 10.1161/CIRCULATIONAHA.114.010921. No abstract available.

PMID:
25223780
19.

Outcome of patients with severe PH due to lung disease with and without targeted therapy.

Lange TJ, Baron M, Seiler I, Arzt M, Pfeifer M.

Cardiovasc Ther. 2014 Oct;32(5):202-8. doi: 10.1111/1755-5922.12084.

PMID:
24909193
20.

Left ventricular support adjustment to aortic valve opening with analysis of exercise capacity.

Camboni D, Lange TJ, Ganslmeier P, Hirt S, Flörchinger B, Zausig Y, Rupprecht L, Hilker M, Schmid C.

J Cardiothorac Surg. 2014 May 20;9:93. doi: 10.1186/1749-8090-9-93.

21.

Tobacco smoke exposure in pulmonary arterial and thromboembolic pulmonary hypertension.

Keusch S, Hildenbrand FF, Bollmann T, Halank M, Held M, Kaiser R, Kovacs G, Lange TJ, Seyfarth HJ, Speich R, Ulrich S.

Respiration. 2014;88(1):38-45. doi: 10.1159/000359972. Epub 2014 May 15.

22.

Six-minute walk distance target in elderly patients with idiopathic pulmonary arterial hypertension - consideration of predicted values.

Lange TJ, Keller A, Arzt M, Pfeifer M.

Int J Clin Pract. 2014 May;68(5):543-50. doi: 10.1111/ijcp.12351. Epub 2014 Jan 29.

PMID:
24472027
23.

Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).

Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange TJ, Behr J, Klose H, Claussen M, Ewert R, Opitz CF, Vizza CD, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper MM.

Circulation. 2014 Jan 7;129(1):57-65. doi: 10.1161/CIRCULATIONAHA.113.004526. Epub 2013 Sep 30.

PMID:
24081973
24.

[Acute right heart failure in pulmonary hypertension].

Lange TJ, Lubnow M.

Dtsch Med Wochenschr. 2013 Oct;138(40):2023-6. doi: 10.1055/s-0033-1349510. Epub 2013 Sep 9. German. No abstract available.

PMID:
24019102
25.

Increased pulmonary artery diameter on chest computed tomography can predict borderline pulmonary hypertension.

Lange TJ, Dornia C, Stiefel J, Stroszczynski C, Arzt M, Pfeifer M, Hamer OW.

Pulm Circ. 2013 Apr;3(2):363-8. doi: 10.4103/2045-8932.113175.

26.

Effects of simvastatin on pulmonary fibrosis, pulmonary hypertension and exercise capacity in bleomycin-treated rats.

Schroll S, Lange TJ, Arzt M, Sebah D, Nowrotek A, Lehmann H, Wensel R, Pfeifer M, Blumberg FC.

Acta Physiol (Oxf). 2013 Jun;208(2):191-201. doi: 10.1111/apha.12085. Epub 2013 Mar 25.

PMID:
23527830
27.

Qualitative echocardiography parameters for prediction of pulmonary hypertension.

Lange TJ, Baumgartner S, Arzt M, Pfeifer M.

Int J Clin Pract Suppl. 2013 May;(179):5-12. doi: 10.1111/ijcp.12068. Epub 2013 Feb 12.

PMID:
23398448
28.

Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry.

Hoeper MM, Huscher D, Ghofrani HA, Delcroix M, Distler O, Schweiger C, Grunig E, Staehler G, Rosenkranz S, Halank M, Held M, Grohé C, Lange TJ, Behr J, Klose H, Wilkens H, Filusch A, Germann M, Ewert R, Seyfarth HJ, Olsson KM, Opitz CF, Gaine SP, Vizza CD, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Pittrow D.

Int J Cardiol. 2013 Sep 30;168(2):871-80. doi: 10.1016/j.ijcard.2012.10.026. Epub 2012 Nov 17.

PMID:
23164592
29.

Endobronchial ultrasound-guided transbronchial needle aspiration in routine care - plenty of benign results and follow-up tests.

Lange TJ, Kunzendorf F, Pfeifer M, Arzt M, Schulz C.

Int J Clin Pract. 2012 May;66(5):438-45. doi: 10.1111/j.1742-1241.2012.02907.x.

PMID:
22512605
30.

Multidetector computed tomography for detection and characterization of pulmonary hypertension in consideration of WHO classification.

Dornia C, Lange TJ, Behrens G, Stiefel J, Müller-Wille R, Poschenrieder F, Pfeifer M, Leitzmann M, Manos D, Babar JL, Stroszczynski C, Hamer OW.

J Comput Assist Tomogr. 2012 Mar-Apr;36(2):175-80. doi: 10.1097/RCT.0b013e31824afbdf.

PMID:
22446355
31.

Pulmonary hypertension due to chronic lung disease: updated Recommendations of the Cologne Consensus Conference 2011.

Hoeper MM, Andreas S, Bastian A, Claussen M, Ghofrani HA, Gorenflo M, Grohé C, Günther A, Halank M, Hammerl P, Held M, Krüger S, Lange TJ, Reichenberger F, Sablotzki A, Staehler G, Stark W, Wirtz H, Witt C, Behr J.

Int J Cardiol. 2011 Dec;154 Suppl 1:S45-53. doi: 10.1016/S0167-5273(11)70492-2.

32.

[Pulmonary hypertension due to chronic lung disease. Recommendations of the Cologne Consensus Conference 2010].

Hoeper MM, Andreas S, Bastian A, Claussen M, Ghofrani HA, Gorenflo M, Grohé C, Günther A, Halank M, Hammerl P, Held M, Krüger S, Lange TJ, Reichenberger F, Sablotzki A, Staehler G, Stark W, Wirtz H, Witt C, Behr J.

Pneumologie. 2011 Apr;65(4):208-18. doi: 10.1055/s-0030-1255970. Epub 2010 Dec 22. German.

33.

[Pulmonary hypertension due to chronic lung disease. Recommendations of the Cologne Consensus Conference 2010].

Hoeper MM, Andreas S, Bastian A, Claussen M, Ghofrani HA, Gorenflo M, Grohé C, Günther A, Halank M, Hammerl P, Held M, Krüger S, Lange TJ, Reichenberger F, Sablotzki A, Staehler G, Stark W, Wirtz H, Witt C, Behr J; German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK).

Dtsch Med Wochenschr. 2010 Oct;135 Suppl 3:S115-24. doi: 10.1055/s-0030-1263318. Epub 2010 Sep 22. German.

PMID:
20862620
34.

Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.

Schlenska-Lange A, Knüpfer H, Lange TJ, Kiess W, Knüpfer M.

Anticancer Res. 2008 Mar-Apr;28(2A):1055-60. Erratum in: Anticancer Res. 2008 May-Jun;28(3b):1965.

35.

A 46-year-old man with dyspnea and hemoptysis 3 years following mitral valve repair.

Lange TJ, Luchner A, Endemann D, Pfeifer M, Pitschner HF, Schulz C.

Chest. 2007 Aug;132(2):704-7. No abstract available.

PMID:
17699145
36.

How judges sentence DUI offenders: an experimental study.

Lange TJ, Greene E.

Am J Drug Alcohol Abuse. 1990;16(1-2):125-33.

PMID:
2330933

Supplemental Content

Loading ...
Support Center